Lorisol S 500mg/250mg Injection
Marketer
Salud Care India Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Lorisol S 500mg/250mg Injection
Combiflox 500mg/250mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial proliferation and halting infection spread. Administration must be solely under a physician's direction; strict adherence to the prescribed schedule is crucial. Complete the full course of treatment, regardless of symptom improvement, as premature cessation can compromise efficacy. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately to your doctor. Seek emergency medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals should consult their physician. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and sufficient hydration will aid recovery. Your physician may order lab tests and diagnostic imaging to monitor treatment response.
Uses of Lorisol S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Lorisol S 500mg/250mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Lorisol S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Lorisol S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Lorisol S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Lorisol S 500mg/250mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counters bacterial defenses, optimizing Ceftriaxone's effectiveness and broadening its antibacterial spectrum.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Lorisol S 500mg/250mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Lorisol S 500mg/250mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Lorisol S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administering Lorisol S 500mg/250mg Injection might cause drowsiness, blurred vision, or dizziness. Refrain from driving while experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Lorisol S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Lorisol S 500mg/250mg Injection cautiously, potentially requiring dosage modification. Medical advice is necessary. Dosage changes for Lorisol S 500mg/250mg Injection are unnecessary for individuals with mild to moderate liver dysfunction.
What if you forget to take Lorisol S 500mg/250mg Injection :
Should you inadvertently omit a scheduled dose of Lorisol S 500mg/250mg Injection, seek immediate medical advice.
Facts to Know About Lorisol S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently